Injection in Patients With Chronic Shoulder Pain
CompletedNot applicableNCT06135038
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Background: Chronic shoulder pain (CSP) is a musculoskeletal disease characterized by pain lasting more than 3 months. Purpose: This study aimed to determine whether pre-treatment injection in CSP treatment contributes to pain, functionality and quality of life. Methods: A total of 110 patients who met the inclusion criteria of the study were divided into 2 groups (55 patients in each group). A standard 15-session physical therapy program (hot pack, transcutaneous electric nerve stimulation(TENS), US and therapeutic exercises) was applied to all patients in both groups. Suprascapular Nerve Block was applied to Group I before treatment. Assessments were made using VAS-Pain, Shoulder Pain and Disability Index (SPADI) and The Nottingham Health Profile (NHP) before and at the end of the treatment and in the posttreatment 3th months.
Study details
- Official title
- Does Shoulder Injection in Patients With Chronic Shoulder Pain Contribute to Physiotherapy?
- Conditions
- Interventions
- Other: Suprascapular nerve block with physical therapy
- Other: Group 2 Physical therapy
- Sponsor
- Uşak University
- Start date
- 2020-02-01
- Primary completion
- 2020-05-01
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Between the ages of 18-65, * Having pain lasting longer than 3 months, * Full range of joint motion * Patients with shoulder pain due to biceps tendinitis, impingement syndrome, rotator cuff diseases (tendinosis, calcific tendonitis, etc.) Exclusion Criteria: * Inflammatory rheumatic disease (rheumatoid arthritis, ankylosing spondylitis, etc.), * Full thickness rotator cuff tear * Glenohumeral disorders (arthritis, osteoarthritis, osteonecrosis, glenohumeral instability) * Regional disorders (cervical radiculopathy, brachial neuritis, entrapment neuropathies, reflex sympathetic dystrophy, neoplasms, etc.) * Diagnosed with metabolic syndrome, diabetes mellitus (DM), hypertension (HT) * Having a diagnosed neuro-psychiatric problem, * Undergoing malignancy treatment, * Having a bleeding disease, * Having an infectious disease with fever, * Who have undergone surgery on the shoulder, * Patients who received physical therapy in the last year
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06135038